BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1365754)

  • 1. Aminocarnitine and related compounds as inhibitors of carnitine transferases: physiologic implications.
    Nutr Rev; 1990 Jun; 48(6):258-60. PubMed ID: 1365754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiketogenic and hypoglycemic effects of aminocarnitine and acylaminocarnitines.
    Jenkins DL; Griffith OW
    Proc Natl Acad Sci U S A; 1986 Jan; 83(2):290-4. PubMed ID: 3455765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue lipid accumulation by L-aminocarnitine, an inhibitor of carnitine-palmitoyltransferase-2. Studies in intact rats and isolated mitochondria.
    Chiodi P; Maccari F; Ramacci MT
    Biochim Biophys Acta; 1992 Jul; 1127(1):81-6. PubMed ID: 1627637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DL-aminocarnitine and acetyl-DL-aminocarnitine. Potent inhibitors of carnitine acyltransferases and hepatic triglyceride catabolism.
    Jenkins DL; Griffith OW
    J Biol Chem; 1985 Nov; 260(27):14748-55. PubMed ID: 3840486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of carnitine palmitoyltransferase leads to induction of 3-hydroxymethylglutaryl coenzyme A reductase activity in rat liver.
    Jansen H; Hoogerbrugge Van der Linden N; Hülsmann WC
    Biochim Biophys Acta; 1990 Jun; 1044(3):390-3. PubMed ID: 2364104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Derivatives of R-aminocarnitine without ammonium moiety as liver carnitine palmitoyltransferase I (L-CPT I) inhibitors.
    Tassoni E; Conti R; Gallo G; Vincenti S; Mastrofrancesco L; Brunetti T; Cabri W; Giannessi F
    ChemMedChem; 2011 Nov; 6(11):1977-80. PubMed ID: 21834096
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibitors of fatty acid oxidation.
    Schulz H
    Life Sci; 1987 Apr; 40(15):1443-9. PubMed ID: 3550347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminocarnitine ureidic derivatives as inhibitors of carnitine palmitoyltransferase I.
    Tassoni E; Conti R; Gallo G; Vincenti S; Dell'Uomo N; Mastrofrancesco L; Ricciolini R; Cabri W; Carminati P; Giannessi F
    ChemMedChem; 2010 May; 5(5):666-9. PubMed ID: 20232438
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the effects of carnitine palmitoyltransferase-1 and -2 inhibitors on rat heart hypertrophy.
    Hülsmann WC; Peschechera A; Schneijdenberg CT; Verkleij AJ
    Cardioscience; 1994 Sep; 5(3):193-7. PubMed ID: 7827256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active-site probes of carnitine acyltransferases. Inhibition of carnitine acetyltransferase by hemiacetylcarnitinium, a reaction intermediate analogue.
    Gandour RD; Colucci WJ; Stelly TC; Brady PS; Brady LJ
    Biochem Biophys Res Commun; 1986 Jul; 138(2):735-41. PubMed ID: 3741430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation and excretion of long-chain acylcarnitine by rat hearts; studies with aminocarnitine.
    Hülsmann WC; Schneijdenberg CT; Verkleij AJ
    Biochim Biophys Acta; 1991 Nov; 1097(4):263-9. PubMed ID: 1742330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of L-aminocarnitine, an inhibitor of fatty acid oxidation.
    Chegary M; Te Brinke H; Doolaard M; Ijlst L; Wijburg FA; Wanders RJ; Houten SM
    Mol Genet Metab; 2008 Apr; 93(4):403-10. PubMed ID: 18077198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different sensitivities of CPT I and CPT II for inhibition by l-aminocarnitine in human skeletal muscle.
    Traufeller K; Gellerich FN; Zierz S
    Biochim Biophys Acta; 2004 Feb; 1608(2-3):149-54. PubMed ID: 14871492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emeriamine, an antidiabetic beta-aminobetaine derived from a novel fungal metabolite.
    Kanamaru T; Shinagawa S; Asai M; Okazaki H; Sugiyama Y; Fujita T; Iwatsuka H; Yoneda M
    Life Sci; 1985 Jul; 37(3):217-23. PubMed ID: 3839282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of carnitine acetyltransferase inhibition on rat hepatocyte metabolism.
    Brass EP; Gandour RD; Griffith OW
    Biochim Biophys Acta; 1991 Oct; 1095(1):17-22. PubMed ID: 1932127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemipalmitoylcarnitinium, a strong competitive inhibitor of purified hepatic carnitine palmitoyltransferase.
    Gandour RD; Colucci WJ; Stelly TC; Brady PS; Brady LJ
    Arch Biochem Biophys; 1988 Dec; 267(2):515-20. PubMed ID: 3214166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemistry and inhibitory activity of long chain fatty acid oxidation of emeriamine and its analogues.
    Shinagawa S; Kanamaru T; Harada S; Asai M; Okazaki H
    J Med Chem; 1987 Aug; 30(8):1458-63. PubMed ID: 3612690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of L-carnitine and L-aminocarnitine on calcium transport, motility, and enzyme release from ejaculated bovine spermatozoa.
    Deana R; Rigoni F; Francesconi M; Cavallini L; Arslan P; Siliprandi N
    Biol Reprod; 1989 Nov; 41(5):949-55. PubMed ID: 2624859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereoisomeric acylamidomorpholinium carnitine analogues: selective inhibitors of carnitine palmitoyltransferase I and II.
    Savle PS; Pande SV; Lee TS; Gandour RD
    Bioorg Med Chem Lett; 1999 Nov; 9(21):3099-102. PubMed ID: 10560732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-carnitine protection in ammonia intoxication. Effect of aminocarnitine on carnitine-dependent metabolism and acute ammonia toxicity.
    Ohtsuka Y; Griffith OW
    Biochem Pharmacol; 1991 Jun; 41(12):1957-61. PubMed ID: 2039546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.